KSR2 is a novel oncogene in TAL1 subtype of T-cell acute lymphoblastic leukemia with potential clinical and prognostic implications
Speaker:
Dr Monika Drobna-Śledzińska, IHG PAS
Date:
30 June 2026
13.00
Location:
IHG PAS seminar room